Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
Dougherty's Pharmacy, Inc. (MYDP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/16/2021 |
REVOKED
| Form REVOKED - Commission order revoking Exchange Act registration [Section 12(j)]: |
| 12/18/2020 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 08/30/2019 |
8-K
| Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Completion of Acquisition or Disposition of Assets, O... |
| 07/12/2019 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Submission of Matters to a Vo... |
| 05/23/2019 |
10-Q/A
| Quarterly Report for the period ended March 31, 2019 [amend] |
| 05/20/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
| 05/15/2019 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/08/2019 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/06/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 04/29/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2018 |
| 04/02/2019 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 02/07/2019 |
8-K
| Quarterly results |
| 11/15/2018 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 08/14/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
| 08/06/2018 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
| 06/15/2018 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits |
| 05/22/2018 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"Dougherty’ s Pharmacy, Inc. Announces Adjournment of Annual Meeting of Stockholders Dallas, Texas, May 22, 2018 – Dougherty’ s Pharmacy, Inc. or today announced that its 2018 Annual Meeting of Stockholders scheduled for May 16, 2018, was adjourned to achieve a quorum on the proposals to be approved. In order to provide additional time for the Company to obtain a quorum, the meeting date has been adjourned to June 12, 2018, at 1:30 PM, to be held at the Corporate Offices located at 5924 Royal Lane, Suite 250, Dallas, Texas, 75230. During the period of the adjournment, the Company will continue to solicit proxies from its stockholders with respect to the proposals set forth in the proxy statement. Only stockholders of record on the record date of April 13, 2018, will be entitled to and are ..." |
|
| 05/22/2018 |
DEFR14A
| Form DEFR14A - Revised definitive proxy soliciting materials: |
| 05/14/2018 |
8-K
| Quarterly results |
| 05/11/2018 |
10-Q
| Quarterly Report for the period ended March 31, 2018 |
| 04/27/2018 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/30/2018 |
8-K
| Quarterly results |
| 03/29/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 02/20/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 01/22/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/04/2017 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"Dougherty’ s Pharmacy, Inc. Announces Two Percent Special Stock Dividend Dallas, Texas, December 04, 2017 – Dougherty’ s Pharmacy, Inc. today announced that its Board of Directors has declared a special two percent stock dividend on the Company’ s common stock outstanding as of December 18, 2017, which is the record date for such stock dividend. This stock dividend will be payable December 27, 2017. The dividend will be issued in the form of additional shares of common stock. Any fractional shares will be rounded up to the nearest whole number. “This action by the Board is a strong endorsement of its confidence in Dougherty’ s growth strategy as well as the underlying strength of our business,” said Jim Leslie, Chairman of Dougherty’ s. “We are pleased to be able to reward our stockholder..." |
|
| 11/13/2017 |
10-Q
| Quarterly Report for the period ended September 30, 2017 |
| 11/13/2017 |
8-K
| Quarterly results |
| 10/12/2017 |
8-K
| Quarterly results |
| 08/28/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/18/2017 |
10-12G/A
| Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] |
| 08/18/2017 |
8-K
| Quarterly results |
| 08/14/2017 |
10-Q
| Quarterly Report for the period ended June 30, 2017 |
| 08/14/2017 |
8-K
| Quarterly results |
|
|
|